FDA Approves First in the World Device to Treat Patients With Congenital Heart Disease
New implant device provides less invasive option to treat pulmonary valve regurgitation for patients with a native or surgically-repaired right ventricular outflow tract
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.